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Pseudomonas aeruginosa is an invasive organism that frequently causes severe tissue damage in diabetic foot ulcers. A major
problem in P. aeruginosa infectionmaybethatthispathogenexhibitsahighdegreeofresistancetoabroadspectrumofantibiotics.
The study aimed to isolate and determine the antimicrobial susceptibility patterns of the P. aeruginosa population from diabetes
patients with foot ulcers attending tertiary care hospitals in and around Coimbatore and their antimicrobial susceptibility pattern.
The study was carried out at the Department of Microbiology, Dr. N.G.P. Arts and Science College, Coimbatore, for a period
of one year (June 2006 to April 2007). The present study comprised 270 pus specimens collected from diabetic patients with
foot ulcers. All pus samples were subjected to gram staining; bacterial culture and subsequently the antibiotic sensitivity to 15
diﬀerent antibiotics for the conﬁrmed P. aeruginosa were performed as per the standard procedures. Eighteen strains (14.28%)
of P. aeruginosa from 270 diabetic foot ulcers were detected. Almost all the strains exhibited a varying degree of resistance to the
antibiotics tested. Multidrug resistance for about 8 to 11 antibiotics was observed among the 55.5% of the isolates. Disk diﬀusion
results show 100% resistance to ampicillin, cefoperazone, erythromycin, norﬂoxacin, and only cefotaxime, ciproﬂoxacin exhibited
greater activity against Pseudomonas aeruginosa.
1.Introduction
Diabetes is a chronic disorder that aﬀects a large segment of
population and is a major public health problem. Diabetes
and foot problems are almost synonymous [1]. A recent
WHO report indicates that India has the largest diabetic
population (19 million in 1995) that is expected to rise to 57
million by 2025 [2]. A commonly accepted deﬁnition of foot
infection is the presence of systemic signs of infection (e.g.,
feverandleucocytosis)orpurulentsecretionsortwoormore
localsymptomsorsigns(redness,warmth,indurations,pain,
or tenderness) [3]. Viswanathan et al. [4] reported that 25%
of diabetic individuals are anticipated to develop severe foot
problems at some point in their lifetime that often end
with amputation. Diabetic foot infections are more severe
and more diﬃcult to treat than infections in nondiabetics.
Polymicrobial etiology has been implicated in the infected
diabetic foot. Gram-negative infections are three-times more
frequent in the diabetic than in non-diabetic individuals [5].
Most infections with Pseudomonas species occur in
compromised hosts. The pathogenicity of these organisms
is based on its ability to produce a variety of toxins and
proteases and also on its ability to resist phagocytosis [6].
Pseudomonasaeruginosaiscommonlyresistanttoantibiotics,
and because of this it is a dangerous and dreaded pathogen.
The only antibiotic agents to which strains are regularly
sensitive are cephalosporins, carbenicillin, colistin, gentam-
icin, polymyxin, quinolones, and streptomycin; however
degrees of cross-resistance between these agents have been
reported [7]. P. aeruginosa is one of the most important
microorganisms that cause clinical problems resulting from
high-resistance to antimicrobial agents. Though it is rarely2 International Journal of Microbiology
found in the normal ﬂora of humans, it is frequently isolated
from patients with burns, cystic ﬁbrosis, and neutropenia
[8].P. aeruginosa maycauseseveretissuedamagein diabetics
and should never be ignored as insigniﬁcant in diabetic
foot ulcers. Moreover, it should never be considered a
contaminants or normal ﬂora, and it should clearly be
considered a pathogen, because it may result in sepsis and
amputation [9].
One of the challenges in managing P. aeruginosa infec-
tions is an inherent resistance mechanism, referred to as
intrinsic resistance. Its multiplicity of resistance mecha-
nisms may render this microbe less amenable to control
by antibiotic cycling [10]. P. aeruginosa is noted for its
metabolic versatility and its exceptional ability to colonize
a wide variety of environments and also for its intrinsic
resistance to a wide variety of antimicrobial agents. The
bacillus almost never causes infections in healthy individuals
and often infects the immunocompromised. Because of its
virulence and the limited choices of eﬀective antimicrobial
agents, treatments of infections by P. aeruginosa are often
diﬃcult [11]. Though a lot of work has been carried out
elsewhere pertaining to P. aeruginosa, the prevalence and
the antimicrobial susceptibility patterns of P. aeruginosa
from diabetes patients with foot ulcers have rarely been
documented in this part of South India. Therefore, the
present study has been carried out to study the prevalence
of P. aeruginosa and their antimicrobial susceptibility by the
Kirby Bauer-Disk Diﬀusion method.
2.MaterialsandMethods
2.1. Sample. The study was based on 270 pus specimens
received for the screening of P. aeruginosa from diabetes
patients with foot ulcers attending tertiary care hospitals
in and around Coimbatore. Specimens included in the
study were from “Soft tissue infection” which includes foot
wound and “limb threatening infections” specimens were
included in the study. Specimens were obtained using aseptic
techniques to avoid contamination and were promptly
transported to the laboratory in a sterile swab in ice-cold
conditions.
2.2. Isolation and Identiﬁcation of Pseudomonas aeruginosa.
Theisolation andidentiﬁcation oftest organisms wascarried
out by the procedures suggested by Valentina and Lalitha
[12]. Identiﬁcation analysis like Gram staining, motility,
catalase, oxidase, pigment production, growth on cetrimide
agar, ability to grow at 42◦C, gelatin hydrolysis, arginine
dihydrolase, acid from Hugh-Leifson’s glucose, and nitrate
reduction tests were carried out.
2.3. Antibiotic Sensitivity Testing (Kirby Bauer-Disk Dif-
fusion Method). Antibiogram was performed using com-
mercially available antibiotic discs (Hi-Media, Mumbai)
with a standard P. aeruginosa ATCC 27853 as a positive
control. Kirby-Bauer, recommended by the CLSI [13], was
used for antimicrobial susceptibility testing. The identi-
ﬁed 18 P. aeruginosa strains were tested against ampi-
cillin (10µg), amikacin (30µg), ceftazidime (30µg), cefo-
taxime (30µg), ciproﬂoxacin (5µg), cefoperozone (75µg),
co-trimoxazole (25µg), erythromycin (10µg), gentamicin
(10µg), imipenem (10µg), norﬂoxacin (10µg), piperacillin
(100µg), tobramycin (30µg), ticarcillin (75µg), and tetracy-
cline (30µg).
3. Results and Discussion
3.1.Patients. Ofthetotal270diabeticpatientssuﬀeringfrom
foot infections, 180 were male and 90 were female. The
male-to-female ratio was 2:1 and the age of the patients
ranged between 36 to 75 years. Very few of these patients
have undergone amputation. Studies conducted in Chennai
have shown that males were more susceptible than females
in the ratio of 8:3 [14]. Previous studies have shown that
males were more susceptible than females in the ratio of 2:1,
which is in accordance with the current study. Predominance
of male over female patients as shown in the study can be
explained by the fact that in our country males are exposed
more to the outside environment becauseof their mobility as
compared to females.
3.2. Isolation Rate. Of the 270 pus specimens of diabetic
patients with foot infections, 180 (66.6%) specimens were
culture positive and the other 90 (33.3%) were negative.
Among the strains, aerobic gram-negative Pseudomonas
species were 126 (70.0%) and other aerobic organisms
comprised 54 (30.0%). From the 126 Pseudomonas species,
18 (14.30%) were found to be P. aeruginosa. Dhanasekaran
et al. [5] reported the prevalence of Pseudomonas species to
be 18.79% from a diabetic centre in Chennai. In a similar
study conducted in a private hospital in Chennai, 29.8%
strains among diabetic foot ulcer patients were P. aeruginosa
[15]. This ﬁnding shows the high prevalence of Pseudomonas
species and P. aeruginosa among diabetes patients with foot
ulcers.
3.3. Antibiogram Pattern of Pseudomonas aeruginosa. The
Mueller Hinton agar-based antibiogram-resistogram pattern
study of P. aeruginosa isolated from foot ulcers of diabetes
patients is shown in Figure 1. Almost all of the eighteen
P. aeruginosa strains screened showed 100% resistance to
ampicillin, erythromycin, and norﬂoxacin, similarly 83.3%
resistance to piperacillin, ticarcillin, and tetracycline, 66.6%
resistance to ceftazidime, imipenem, gentamicin, amikacin,
tobramycin, and cotrimoxazole and 50.0% resistance to cef-
operazone. However, 15 (83.3%) P. aeruginosa strains were
susceptible to cefotaxime. Multidrug resistance for about 8
to 11 antibiotics was observed among 55.5% of the strains
(Table 1). No single antibiotic showed 100% sensitivity to all
P. aeruginosa strains. Resistance was least with cefotaxime
(16.6%), followed by an intermediate resistance of 66.7%
observed for ciproﬂoxacin.
India has the largest number of diabetic individuals
and appreciably poor economic conditions; the study onInternational Journal of Microbiology 3
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Figure 1: Antimicrobial susceptibility patterns of Pseudomonas
aeruginosa among diabetes patients with foot ulcers.
Table 1: Multidrug resistance patterns of P. aeruginosa of diabetic
foot ulcers.
No. of drugs resistant No. of isolates
(n = 18) Resistance (%)
≥8 18 100
≥9 15 83.3
≥10 13 72.2
≥11 10 55.5
≥12 7 38.8
≥13 5 27.7
≥14 2 11.1
≥15 0 0
this intrinsic resistant organism in diabetic foot infections
assumes signiﬁcance. The present study has shown the
incidence of P. aeruginosa to be 14.3% in diabetic foot
ulcers, which is signiﬁcant when compared to previous
studies. In accordance with earlier observations [16], the
current study has demonstrated that P. aeruginosa strains
isolated from foot ulcers are more resistant to antimicrobial
agents. This may be due to the fact that the strains
isolated from clinical specimens have been subjected to
the selective actions of both disinfectants and antibiotics
[16]. As expected, the strains were resistant to imipenem,
piperacillin, erythromycin, ticarcillin, tetracycline, gentam-
icin, co-trimoxazole, and amikacin indicating the emergence
of multidrug-resistant strains. Antibiogram also revealed
that cefotaxime and ciproﬂoxacin retained high levels of
antipseudomonal activity and cefoperazone, gentamicin,
ceftazidime, amikacin, imipenem, and tobramycin had the
least activity. Ciproﬂoxacin and cefotaxime were found to be
better choices for diabetes patients with foot ulcers in this
part of the region when compared to gentamicin, imipenem,
piperacillin, and other third-generation cephalosporins. The
present study thus revealed the importance of P. aeruginosa
fromdiabetespatientswithfootulcers,whichisnecessaryfor
proper management of diabetes patients.
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